Alterations of Phosphodiesterases in Adrenocortical Tumors

Fady Hannah-Shmouni1, Fabio R Faucz1, Constantine A Stratakis1

  • 1Program on Developmental Endocrinology and Genetics (PDEGEN), Section on Endocrinology and Genetics (SEGEN), National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH) , Bethesda, MD , USA.

Frontiers in Endocrinology
|September 15, 2016
PubMed

Insights

Altered cyclic adenosine monophosphate (cAMP) signaling, particularly involving phosphodiesterases PDE11A and PDE8B, is linked to benign adrenocortical tumors (ACTs). These genetic variants increase the risk of developing ACTs and other cancers.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Cyclic adenosine monophosphate (cAMP) signaling is crucial in adrenal function and implicated in benign adrenocortical tumors (ACTs) causing Cushing syndrome (CS).
  • Phosphodiesterases (PDEs) regulate intracellular cAMP levels, and specific PDEs, PDE11A and PDE8B, are known to bind cAMP.

Purpose of the Study:

  • To review the role of PDE11A and PDE8B in the predisposition to adrenocortical tumors (ACTs).
  • To summarize current knowledge on PDE11A and PDE8B involvement in ACTs and other cancers.

Main Methods:

  • Review of existing literature, including genome-wide association studies and genetic analyses of tumor samples.
  • Analysis of genetic variants and expression patterns of PDE11A and PDE8B in various tumor types.

Main Results:

  • Inactivating mutations and variants in PDE11A and PDE8B predispose individuals to ACTs, including micronodular and macronodular hyperplasia and cortisol-producing adenomas.
  • PDE11A alterations are also found in testicular germ cell tumors and prostate cancer, suggesting broader roles for these PDEs in tumorigenesis.

Conclusions:

  • PDE11A and PDE8B play a significant role in the development of ACTs, likely through their regulation of cAMP levels.
  • Dysregulation of these phosphodiesterases represents a potential risk factor for multiple tumor types.

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.7K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
55.2K
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
6.3K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.4K